Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


06.08.2018

2 Arch Virol
1 Biochem Biophys Res Commun
2 J Infect Dis
4 Lancet Infect Dis
2 PLoS One
1 Proc Natl Acad Sci U S A
4 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. AL KHATIB HA, Al Thani AA, Yassine HM
    Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017.
    Arch Virol. 2018 Jul 31. pii: 10.1007/s00705-018-3962.
    PubMed     Text format     Abstract available

  2. JANG Y, Jin M, Seo SH
    Histamine contributes to severe pneumonia in pigs infected with 2009 pandemic H1N1 influenza virus.
    Arch Virol. 2018 Jul 31. pii: 10.1007/s00705-018-3973.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  3. WANG J, Liu M, Ding N, Li Y, et al
    Vaccine based on antibody-dependent cell-mediated cytotoxicity epitope on the H1N1 influenza virus increases mortality in vaccinated mice.
    Biochem Biophys Res Commun. 2018 Jul 28. pii: S0006-291X(18)31633.
    PubMed     Text format     Abstract available


    J Infect Dis

  4. TREANOR J
    Influenza Challenge and the Challenge of Drug Development.
    J Infect Dis. 2018 Jul 26. pii: 5060130. doi: 10.1093.
    PubMed     Text format    

  5. YOGARATNAM J, Rito J, Kakuda TN, Fennema H, et al
    Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study.
    J Infect Dis. 2018 Jul 26. pii: 5060129. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  6. SHANKS GD, Wilson N, Kippen R, Brundage JF, et al
    Host and viral genetic diversity can help explain mortality during the 1918-21 influenza pandemic in the Pacific region - Authors' reply.
    Lancet Infect Dis. 2018;18:834.
    PubMed     Text format    

  7. ATWELL JE, Karron RA
    Vaccination against respiratory syncytial virus in pregnancy.
    Lancet Infect Dis. 2016;16:1330-1331.
    PubMed     Text format    

  8. HANON E, Van der Most R, Del Giudice G, Rappuoli R, et al
    Short-term and mid-term solutions for influenza vaccines.
    Lancet Infect Dis. 2018;18:832-833.
    PubMed     Text format    

  9. TARANTOLA A, Horwood P, Richard V, Quintana-Murci L, et al
    Host and viral genetic diversity can help explain mortality during the 1918-21 influenza pandemic in the Pacific region.
    Lancet Infect Dis. 2018;18:833-834.
    PubMed     Text format    


    PLoS One

  10. AGUSTININGSIH A, Trimarsanto H, Restuadi R, Artika IM, et al
    Evolutionary study and phylodynamic pattern of human influenza A/H3N2 virus in Indonesia from 2008 to 2010.
    PLoS One. 2018;13:e0201427.
    PubMed     Text format     Abstract available

  11. MACHABLISHVILI A, Chakhunashvili G, Zakhashvili K, Karseladze I, et al
    Overview of three influenza seasons in Georgia, 2014-2017.
    PLoS One. 2018;13:e0201207.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  12. DENG L, Chang TZ, Wang Y, Li S, et al
    Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
    PubMed     Text format     Abstract available


    Vaccine

  13. NOH JY, Choi WS, Song JY, Lee HS, et al
    Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)30987.
    PubMed     Text format     Abstract available

  14. MACHADO A, Kislaya I, Santos AJ, Gaio V, et al
    Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditions.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)31010.
    PubMed     Text format     Abstract available

  15. ALBRIGHT K, Hurley LP, Lockhart S, Gurfinkel D, et al
    Attitudes about adult vaccines and reminder/recall in a safety net population.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31543.
    PubMed     Text format     Abstract available

  16. STATLER VA, Albano FR, Airey J, Sawlwin DC, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59months of age: A phase 3, randomized, noninferiority study.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)31005.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: